Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
September 1993 to March 1994
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[[(4-methylphenyl)sulfonyl]methyl]formamide
EC Number:
700-490-2
Cas Number:
36635-56-0
Molecular formula:
C9H11NO3S
IUPAC Name:
N-[[(4-methylphenyl)sulfonyl]methyl]formamide
Details on test material:
- Name of test material (as cited in study report): CGA 224433 tech.
- Physical state: solid
- Purity: 100%
- Lot/batch No.: P.709027
- Other:

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Initial body weight range: 168 - 205g
- Fasting period before study: overnight
- Housing: Macrolon cages type 4, std soft wood bedding
- Diet (e.g. ad libitum): NAFAG 890 Tox ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 55 +/- 10%
- Air changes (per hr): 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12hour/day light cycle

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
arachis oil
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 500, 1000 & 2000mg/kg
- Amount of vehicle (if gavage): 10ml/kg body weight
Doses:
One single dose by gastric intubation
No. of animals per sex per dose:
5 males at 1000mg/kg
15 females, 5 per dose - 500, 1000 & 2000mg/kg
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: immediately before administration, then on days 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
LD50 values for females and both sexes computed using the Logit Model (J Berkson, J. Am. Stat. Ass 39 (1944), 357-365)

Results and discussion

Mortality:
Nine mortalities occured in this study
3 of 5 males in the 1000mg/kg bw dose group
0 of 5 females in the 500mg/kg bw dose group
1 of 5 females in the 1000mg/kg bw dose group
5 of 5 females in the 2000mg/kg bw dose group
Clinical signs:
Piloerection, abnormal body postures and dyspnea were seen being common symptoms in acute tests.
Additionally reduced spontaneous activity was observed in the animals of all dose groups.
Ataxia was seen in females and males dosed with 1000mg/kg bw 1 to 5 days after administration.
Diarrhea was found on the males of the 1000mg/kg bw dose group 5hrs after administration. 1 male of this group was found moribund 3 to 4 days after administration before death on day 5 after administration.

Surviving animals recovered within 9 days.
Body weight:
165 - 205 g
Gross pathology:
At autopsy, a haemorrhagic thymus was detected in one male of the 1000mg/kg bw dose group and one female in the 2000mg/kg bw dose group.

Any other information on results incl. tables

           
           
           
           
           
           
           
           
           
           
           
           
           
           
           

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Executive summary:

Upon an oral administration and a 14 day post treatment observation period, several mortalities occured at 1000mg/kg and greater. All surviving animals recovered from observed effects within 9 days. At necropsy, a haemorraged thymus was detected in two animals.

Therefore LD50 value set at >500mg/kg but <1000mg/kg for males, 1155 mg/kg for females, 1072 for both sexes.

Thus this substance should be assigned the hazard phrases

EU Classification - R22 harmful if swallowed

GHS Classifiaction - Oral Toxicity Category 4